The investigation of PSDEP is full of potential pitfalls due to many potentially confounding factors. As will be discussed below, PSDEP may have many nonpsychotic phenotypical admixtures that can be categorically or dimensionally defined and may be inherent to the disorder or not. As far as the categorically defined ‘comorbidity’ is concerned, to improve the assessment of potentially
relevant subDorsomorphin AMPK inhibitor categories of sellekchem depression we used the highly anxious retarded (HAR) subcategory and the subcategory with above-normal AVP concentration (ANA) that have been derived from melancholia and familial depression [de Winter et al. 2004; Goekoop Inhibitors,research,lifescience,medical et al. 2006; Goekoop and Wiegant, 2009], next to the melancholic subtype according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) [American Psychiatric Association, 1994]. In previous studies that only used DSM categories, one study found increased levels of plasma NE in a mixed group of patients Inhibitors,research,lifescience,medical with melancholia (n = 6) and PSDEP (n
= 4) compared with a group of patients with nonmelancholia and non-PSDEP (n = Inhibitors,research,lifescience,medical 7) [Kelly and Cooper, 1998]. This corresponds with cerebrospinal fluid NE being increased in melancholia compared with normal controls [Wong et al. 2000]. Another study found no increase in plasma NE in four patients with PSDEP compared with 18 patients with non-PSDEP [Rothschild et al. 1987]. This negative finding may have been due to
the low number of patients with PSDEP, but Inhibitors,research,lifescience,medical also due to lack of control for confounding variables. As far as the multidimensional background of PSDEP is concerned, we used three global dimensions of psychopathology, called Emotional Dysregulation, Motivational Inhibition (Retardation) and Autonomic Dysregulation (Anxiety). These dimensions represent Inhibitors,research,lifescience,medical the nonmanic and nonpsychotic psychopathology of the six-dimensional global structure of psychopathology assessed by the semi-standardized interview of the Comprehensive Psychopathological Rating Scale (CPRS) [Goekoop et al. 1992]. Since Emotional Dysregulation correlates Dacomitinib 0.95 with the Montgomery Asberg Depression Rating Scale (MADRS) [Montgomery and Asberg, 1979; Goekoop et al. 1994], we used this dimension as the general measure of severity of depression. The potential usefulness of this approach is predicted by several findings. A previous study combined dimensions of psychopathology and subcategories of depression, and found that plasma NE was related to the melancholic subcategory and to Retardation in a group of patients with depression (mostly melancholic or previously melancholic depression compared with normal control subjects) [Roy et al. 1985a]. NE was related to Anxiety in the melancholic subcategory.